These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25304095)
1. Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism. Wojcik M; Janus D; Zygmunt-Gorska A; Starzyk JB J Endocrinol Invest; 2015 Mar; 38(3):345-9. PubMed ID: 25304095 [TBL] [Abstract][Full Text] [Related]
2. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome. Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357 [TBL] [Abstract][Full Text] [Related]
3. Prepubertal ultra-low-dose estrogen therapy is associated with healthier lipid profile than conventional estrogen replacement for pubertal induction in adolescent girls with Turner syndrome: preliminary results. Ruszala A; Wojcik M; Zygmunt-Gorska A; Janus D; Wojtys J; Starzyk JB J Endocrinol Invest; 2017 Aug; 40(8):875-879. PubMed ID: 28397183 [TBL] [Abstract][Full Text] [Related]
4. The association of FGF23 levels in obese adolescents with insulin sensitivity. Wojcik M; Janus D; Dolezal-Oltarzewska K; Drozdz D; Sztefko K; Starzyk JB J Pediatr Endocrinol Metab; 2012; 25(7-8):687-90. PubMed ID: 23155694 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome. O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295 [TBL] [Abstract][Full Text] [Related]
6. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026 [TBL] [Abstract][Full Text] [Related]
8. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents. Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185 [TBL] [Abstract][Full Text] [Related]
9. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. Van Pareren YK; De Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Drop SL J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334 [TBL] [Abstract][Full Text] [Related]
10. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city]. Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716 [TBL] [Abstract][Full Text] [Related]
11. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy. Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088 [TBL] [Abstract][Full Text] [Related]
12. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome]. Liang L; Fu JF; Zou CC; Hong F; Wang CL; Wang XM Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):118-21. PubMed ID: 16624028 [TBL] [Abstract][Full Text] [Related]
13. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study. Liang S; Hu Y; Liu C; Qi J; Li G Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122 [TBL] [Abstract][Full Text] [Related]
15. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters. Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences. Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392 [TBL] [Abstract][Full Text] [Related]
17. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome? Vaccaro F; Cianfarani S; Pasquino AM; Boscherini B Metabolism; 1995 Aug; 44(8):1033-7. PubMed ID: 7637644 [TBL] [Abstract][Full Text] [Related]
18. The relationship of periaortic fat thickness and cardiovascular risk factors in children with Turner syndrome. Akyürek N; Atabek ME; Eklioglu BS; Alp H Pediatr Cardiol; 2015 Jun; 36(5):925-9. PubMed ID: 25601134 [TBL] [Abstract][Full Text] [Related]
19. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. Wooten N; Bakalov VK; Hill S; Bondy CA J Clin Endocrinol Metab; 2008 Jun; 93(6):2109-14. PubMed ID: 18349057 [TBL] [Abstract][Full Text] [Related]
20. Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study. Błaszczyk E; Shulhai AM; Gieburowska J; Barański K; Gawlik AM Front Endocrinol (Lausanne); 2023; 14():1216464. PubMed ID: 37497348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]